Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Video
All Video TypesAJMC TVGuidelinesInsightsOnLocationPayer PerspectivesPeer ExchangePost Conference PerspectivesShortsStakeholder Summit
Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
More
Conferences
Conference CoverageConference ListingPost Conference Perspectives
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Video
  • Podcasts
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement
|Videos|February 3, 2022

Supporting MRD Availability

Our experts tell us how we can support the availability of MRD for more patients.

Advertisement

Episodes in this series

EP. 1 Explaining Molecular Residual Disease
EP. 1 Explaining Molecular Residual Disease
EP. 2 The Evolution of Circulating Tumor DNA in Oncology
EP. 2 The Evolution of Circulating Tumor DNA in Oncology
EP. 3 MRD Assessments
EP. 3 MRD Assessments
EP. 4 MRD Results and Guiding Treatment Decisions
EP. 4 MRD Results and Guiding Treatment Decisions
EP. 5 MRD and Value-Based Care Models
EP. 5 MRD and Value-Based Care Models
EP. 6 Supporting MRD Availability
Now Playing
EP. 6 Supporting MRD Availability
EP. 7 INSPIRE and IMvigor011 Trials
EP. 7 INSPIRE and IMvigor011 Trials
EP. 8 Potential Changes for MRD in the Future
EP. 8 Potential Changes for MRD in the Future
Advertisement
News Network
|
Video Series
|
Clinical
|
Guiding Appropriate Cancer Treatment with Molecular Residual Disease Testing

Related Content

Advertisement
Myeloproliferativedisorder | Image Credit: © ibreakstock-stock.adobe.com

5 Ongoing Clinical Trials in Myeloproliferative Neoplasms

ByMaggie L. Shaw
June 19th 2026
Principal investigator Sara A. Hurvitz, MD, said results with the gedatolisib combinations show they could be the new standard of care in HR+/HER2- advanced breast cancer. | Image: Fred Hutch

In VIKTORIA-1, Gedatolisib Combos Cut Risk of Progression by Half vs Alpelisib in PIK3CA-Mutant Advanced Breast Cancer

ByMary Caffrey
June 19th 2026
Dr Julie Kanter | Image Credit: Inherited Blood Disorders

Trial Eligibility Requirements Capture Only a Fraction of Adults With Sickle Cell Disease: Julie Kanter, MD

ByBrooke McCormick,Julie Kanter, MD
June 19th 2026

Fibrosis Belongs at Center of MASH End Points: Zobair M. Younossi, MD

ByLaura Joszt, MA,Zobair M. Younossi, MD
June 19th 2026

Verekitug Could Address Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps: Joseph K. Han, MD

BySabrina McCrear,Joseph K. Han, MD
June 18th 2026
Advertisement
Advertisement

Trending on AJMC

1

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

2

EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”

3

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

4

How MCOs Should Be Preparing for the OBBBA's Medicaid Cuts: David Brueggeman, MBA

5

Early Data Show Revumenib Offers Maintenance Option in AML Following SCT

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text